TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04637841

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiology Taping Appliying
Description: Kinesiology tape will be applied to left foot plantar fascia of the participants in diabetes mellitus and control group.~During taping, participants will lie in the prone position while the knee joint will be kept 90 degrees of flexion and the ankle joint in a neutral position. A Palm Shape taping procedure will be applied to the plantar fascia.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiology Taping Appliying
Description: Kinesiology tape will be applied to left foot plantar fascia of the participants in diabetes mellitus and control group.~During taping, participants will lie in the prone position while the knee joint will be kept 90 degrees of flexion and the ankle joint in a neutral position. A Palm Shape taping procedure will be applied to the plantar fascia.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Release Technique Appliying
Description: Myofascial release technique will be applied (during 5 minutes) to right foot plantar fascia of the participants in diabetes mellitus and control group~During appliying technique, participants will lie in the prone position while the knee joint will be kept 90 degrees of flexion and the ankle joint in a neutral position.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Release Technique Appliying
Description: Myofascial release technique will be applied (during 5 minutes) to right foot plantar fascia of the participants in diabetes mellitus and control group~During appliying technique, participants will lie in the prone position while the knee joint will be kept 90 degrees of flexion and the ankle joint in a neutral position.
Study: NCT06331507

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CMR patch
Description: The Cardiac Magnetic Resonance (MR) patch is a sequence modification for enhancing the images in patients with devices (CIED) for assessing heart muscle scar. The Philips tested patch supports multiple cardiac MR imaging enhancements compiled from several individual patches generated by multiple Philips MR research collaborators for use on 1.5 Tesla Philips scanners.
Study: NCT05890417

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire
Description: Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and 6 months after starting hormone replacement therapy
Study: NCT06205784

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitative exercise
Description: 3-4 weeks of heavy resistance exercise
Study: NCT05235152

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual individual physiotherapy care
Description: Usual and individual physiotherapy care guidelines were developed through a round-table discussion involving experts in musculoskeletal health. From the round-table discussion, the consensus as reflecting best-practices for the rehabilitation of musculoskeletal rehabilitation supported an active exercise rehabilitation approach which includes strengthening and neuromuscular training exercises. Furthermore, the following treatments are considered in addition to active exercises:~* Range of motion: active, active-assisted, passive, repeated movements (Mulligan or McKenzie);~* Stretching / manual therapy: mobilizations, manipulation, neural mobility, active release therapy;~* Individual proprioceptive training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group-supervised physiotherapy training programs
Description: Three group-supervised physiotherapy training programs (The lumbar, the upper extremity and the lower extremity training programs) were developed for military members with musculoskeletal conditions. They are composed of stations that each include several exercises of varying levels of difficulty. Group size will vary between 5 to 20 participants for one physiotherapist, and each military member performs his/her own exercises. During a typical session, the participant and therapist will choose one exercise to perform per station according to two main criteria: severity of the condition and the ability to perform the exercises optimally. The level of supervision is adapted to the participant's needs and performance. Progression in the programs leads to the execution of exercises that simulate functional and occupational tasks.
Study: NCT06140433

Intervention type: DEVICE
Group type: OTHER
Intervention: VSC-MEDlib
Description: VSC-MEDlib will be used for post-processing
Study: NCT05901337

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Cupping therapy with convential medical treatment
Description: Device:Cupping therapy device~Group A participants received Dry cupping therapy one session per week for 8 weeks with 6 days intervals between sessions and with cups applied to the skin for around 8 minutes. (In addition to convential medical treatment for 8 weeks in the form of :~1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger .~2. Vitamine C: The recommended dietary dose 200 mg/day vitamin c~3. Anticoagulation drugs (blood thinners)Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Cupping therapy with convential medical treatment
Description: Device:Cupping therapy device~Group A participants received Dry cupping therapy one session per week for 8 weeks with 6 days intervals between sessions and with cups applied to the skin for around 8 minutes. (In addition to convential medical treatment for 8 weeks in the form of :~1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger .~2. Vitamine C: The recommended dietary dose 200 mg/day vitamin c~3. Anticoagulation drugs (blood thinners)Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Convential medical treatment
Description: Group B participants received convential medical treatment for 8 weeks in the form of :~1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger .~2. Vitamine C: The recommended dietary dose 200 mg/day vitamin C~3. Anticoagulation drugs (blood thinners)Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Convential medical treatment
Description: Group B participants received convential medical treatment for 8 weeks in the form of :~1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger .~2. Vitamine C: The recommended dietary dose 200 mg/day vitamin C~3. Anticoagulation drugs (blood thinners)Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .
Study: NCT06011694

Intervention type: OTHER
Intervention: MERCURY test, health questionnaires and annual routine physical exams
Description: Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.
Study: NCT05919550

Intervention type: DRUG
Intervention: search for a clozapine intake
Description: search for a clozapine intake
Study: NCT05266469

Intervention type: OTHER
Intervention: Ofatumumab
Description: There is no treatment allocation. Patients administered Ofatumumab by prescription will be enrolled.

Intervention type: OTHER
Intervention: Ocrelizumab
Description: There is no treatment allocation. Patients administered Ocrelizumab by prescription will be enrolled.
Study: NCT06172231

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Instrument Assisted Soft tissue mobilization
Description: The treatment processes consist of Four phases: warm up (heat), Graston Technique®, passive stretching and cryotherapy.6_10 long strokes on Hamstring and Rectus femoris by using G1 instrument .Brief bouts (30 - 60 s) of deeper and more specific. Frequency: 4 sessions in 4-week period. Duration: 15_35 min each session.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional therapy
Description: 5 min moist Hot pack ,Patellar joint mobilizations and Tibiofemoral ,Maitland grades III and IV (5 oscillations in first week) ,PROMs of knee joint ( 5 reps) ,Quad sets ( 5 reps with 5 sec hold)Progression: 5 repetition of each exercise would be add in every week ,Frequency: 4 sessions in 4-week period Duration: 15_ 35 min each session.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional therapy
Description: 5 min moist Hot pack ,Patellar joint mobilizations and Tibiofemoral ,Maitland grades III and IV (5 oscillations in first week) ,PROMs of knee joint ( 5 reps) ,Quad sets ( 5 reps with 5 sec hold)Progression: 5 repetition of each exercise would be add in every week ,Frequency: 4 sessions in 4-week period Duration: 15_ 35 min each session.
Study: NCT05562245

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing-Based Breastfeeding Education
Description: Motivational interviewing is basically a directive and client-centered psychosocial intervention used to help individuals discover and analyze ambivalent emotions related to their health behaviors, to learn new skills and to improve their existing skills. One of the main guiding principles in motivational interviewing is self-support and empowerment. The interviews consist of one to four sessions lasting between 7.5-60 minutes.~A total of four motivational interviews will be held with the mothers in the experimental group.
Study: NCT05998681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breastfeeding and Basic Maternal-Neonatal Care and mobile messages
Description: Participants in the experimental group were provided with education on Breastfeeding and Basic Maternal-Neonatal Care at the hospital and mobile messages were sent with the same content as education program for 6 weeks after discharge.
Study: NCT05865223

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie exercise program
Description: MacKenzie extension exercise program for cervical spine

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical therapy
Description: hot pack for 15 minutes will be given followed by joint mobilization,and home exercise program.
Study: NCT04197362

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation
Description: Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed. They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity. The positions of each marker will be recorded through the motion capture system. Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded. For walking data, two trials of 15 seconds each will be recorded. The second trial will be a redundancy in the setting of potential significant marker dropout.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation
Description: Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed. They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity. The positions of each marker will be recorded through the motion capture system. Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded. For walking data, two trials of 15 seconds each will be recorded. The second trial will be a redundancy in the setting of potential significant marker dropout.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation
Description: Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed. They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity. The positions of each marker will be recorded through the motion capture system. Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded. For walking data, two trials of 15 seconds each will be recorded. The second trial will be a redundancy in the setting of potential significant marker dropout.
Study: NCT04866953

Intervention type: OTHER
Intervention: Blood transfusion
Description: Number of units of blood received within 24 hours of admission

Intervention type: OTHER
Intervention: Blood transfusion
Description: Number of units of blood received within 24 hours of admission
Study: NCT05119062

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Usual care
Description: Families in the control group will be provided with routine care, including regular antenatal check ups, one bed side education (within 24 hours after delivery), one group session with discharge precautions (3rd to 5th day postpartum), two home visits (first week and second week after discharge respectively), and two physical body check at hospital on the 30th and 42nd day postpartum. Contents of the bed side education, pre-discharge education and home visits focuses on health related information, such as postpartum care, infant care and breastfeeding, etc.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: an online intergenerational co-parenting programme+usual care
Description: The program is proposed to include five sessions, with three antenatal sessions to be offered weekly during the 34-36 weeks gestation and two postnatal sessions weekly starting from the first week after discharge from hospital. The intervention will be delivered online.The program is designed for the intergenerational co-parenting families to undertake with parents together with grandmothers. The online courses will be delivered by an online platform in the study hospital. The first session will be pushed to participants in the intervention group within 2 days (around 34 weeks gestation) after recruitment. The second and third session will be pushed around 35 and 36 weeks gestation separately. The first postnatal session will be provided around the first to second week postpartum; and second postnatal session will be provided around the third to fourth week postpartum.
Study: NCT04655027

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roxadustat
Description: The starting dose of roxadustat will be in accordance with the China package insert, and will depend on the body weight of the patient: 100 mg (45 to \< 60 kg) or 120 mg (≥ 60 kg) in patients on dialysis; 70 mg (40 to \< 60 kg) or 100 mg (≥ 60 kg) in non-dialysis patients.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rHuEPO
Description: The starting dose of rHuEPO will be in accordance to the dosage approved in rHuEPO China package insert (patients on weekly dose of 6000 IU \[dosing will BIW\], and patients on weekly dose of \>6000 IU \[dosing will TIW\]) and on patient's haemoglobin levels.
Study: NCT06073002

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: home-based concurrent exercise
Description: 3 weekly sessions of home-based concurrent exercise on non-consecutive days. Resistance exercise is comprised of lunges, hip thrusts, pushups, resistance band rows, core and performed for 3 sets with 15-20 repetitions at an RPE of 14-18 (6-20 BORG scale). Endurance exercise can be done by the mode of choice and is monitored by heartrate zones. Sessions are of low to moderate intensity (below VT2) and the duration will be slowly increased for 20-40min.
Study: NCT06560957

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Time restricted eating
Description: Time restricted eating involves restricting the window in which calories are consumed to 8-10 hours, without altering diet quality or caloric intake. In this study, time restricted eating will be a consistent 10-h eating window between 06:00 and 19:00, considered an early TRE pattern, for all days of the week, as chosen by the participant. They will need to consume all food and beverages (except water) during this window for the duration of the 8-week intervention.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Eating ad libitum with nutritional counselling
Description: Nutritional counselling will include customized advice delivered by a registered dietician about dietary choices while allowing individuals to eat at any time of day.
Study: NCT04614298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KHK4827-Active
Description: Single SC administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: KHK4827-Placebo
Description: Single SC administration
Study: NCT06343116

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab injection
Description: Nimotuzumab will be administered weekly (dose of nimotuzumab depends on part A) until disease progression, unacceptable toxicity, withdrawal of consent or death due to any cause.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered weekly (dose of placebo depends on part A) until disease progression, unacceptable toxicity, withdrawal of consent or death due to any cause.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Trifluridine/tipiracil
Description: Trifluridine/tipiracil will be administered (35 mg/m2) twice daily, 5 days a week, with 2 days of rest, for 2 weeks, followed by a 14-day rest.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil
Description: Trifluridine/tipiracil will be administered (35 mg/m2) twice daily, 5 days a week, with 2 days of rest, for 2 weeks, followed by a 14-day rest.
Study: NCT04998864

Intervention type: DEVICE
Intervention: Magnetic Resonance guided Focused ultrasound (MRgFUS)
Description: FUS involves the application of acoustic energy at low frequencies from over 1000 individual transducers into distinct body targets.
Study: NCT06324877

Intervention type: DRUG
Group type: OTHER
Intervention: Nicotinamide riboside
Description: Oral capsule Nicotinamide Riboside 25mg/kg/day divided into 3 equal doses
Study: NCT05191966

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subcostal Anterior Quadratus Lumborum Block
Description: S-QLB3 block will be performed 30 min. before general anesthesia. For anterior QL block via subcostal approach, 0.4 ml/kg of 0.25% bupivacaine + 1:400.000 adrenaline will be injected into the interfacial plane between the QLM and PMM.~IV-PCA: The requested dose will be 20µg/kg morphine, the lock-in time will be 6-10 minutes, the 4-hour limit will be 80% of the total calculated dose.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Paravertebral Block
Description: TPVB block will be performed 30 min. before general anesthesia. TPVB will be performed at T10 transverse process level, 0.4 ml/kg of 0.25% bupivacaine + 1:400.000 adrenaline will be injected into the paravertebral space.~IV-PCA: The requested dose will be 20µg/kg morphine, the lock-in time will be 6-10 minutes, the 4-hour limit will be 80% of the total calculated dose.
Study: NCT06175286

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POWERBreath Plus Medium Resistance training device
Description: 30 inspirations with the POWERBreath Plus Medium Resistance training device, twice per day for 5 weeks
Study: NCT04936516

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal intubation
Description: Endotracheal intubation using either McGrath or C-MAC video laryngoscopy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal intubation
Description: Endotracheal intubation using either McGrath or C-MAC video laryngoscopy
Study: NCT04511897

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: An'ningpai
Description: An'ningpai Enteric Soft Capsules was a kind of expectorant, comprised with Eucalyptol, Limonene and Pinene. 300 mg, oral, three times daily for 12 months.
Study: NCT06312865

Intervention type: DEVICE
Intervention: Ophthalmic exam
Description: include best corrected visual acuity and cycloplegic refraction data
Study: NCT05313724

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mind-Body Online Therapy
Description: There are 8 different modules (e.g. relaxation, mindfulness, stress management, disease management, nutrition and exercise behavior) with a mind-body focus available for the patients to independently (time, location) work on.
Study: NCT04987866

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: vibration device , Beauty bar facial massaging device, T-Shape Electric Sign Face Massage Tools, Dangshan, China
Description: The vibration device is a reusable, handheld device with a battery-powered motor and a vibration frequency of approximately 6000 times per minute (Beauty bar facial massaging device, T-Shape Electric Sign Face Massage Tools, Dangshan, China)
Study: NCT05577728

Intervention type: DRUG
Intervention: New use of semaglutide injection
Description: New use of semaglutide injection dispensing claim is used as the exposure.

Intervention type: DRUG
Intervention: New initiation of standard of care (SGL2i, 2nd generation SU, DPP-4i and GLP-1 RA except for semaglutide inj or oral)
Description: New initiation of standard of care (SGL2i, 2nd generation SU, DPP-4i and GLP-1 RA except for semaglutide inj or oral) dispensing claim is used as the reference.
Study: NCT06278948

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group TP
Description: Application full face, twice daily, in the morning and at bedtime for 4 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Group CYS
Description: Application short contact, of thin layer once daily at bedtime for 4 months
Study: NCT01493895

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: standard hoem treatment
Description: All treatments will be carried out by trained study caregivers that will give standard treatment to all the participants under their care.~Every treatment will consist of the following steps:~A thorough rinse with an antiseptic soap (Septal scrub) with a stream of warm water.~Drying of the foot with an absorbable disposable paper towel. Using clean latex gloves the caregiver will beam the ulcer with LLLT 808, B-cure laser machine in the following method.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LLLT-808 B-cure laser machine
Description: From the day of entering the study, ulcers will be treated twice daily regardless of the treatment that was used until then.~All treatments will be carried out by trained study caregivers that will give standard treatment to all the participants under their care.~Every treatment will consist of the following steps:~A thorough rinse with an antiseptic soap (Septal scrub) with a stream of warm water.~Drying of the foot with an absorbable disposable paper towel. Using clean latex gloves the caregiver will beam the ulcer with LLLT 808, B-cure laser machine in the following method.~The part of the laser machine from which the laser beam is radiating - the beam guard, will be cleaned with a disposable swab of 70% alcohol. The cleaning will be performed while the machine is pointing downwards.